S&P GSCI Nov '24 (GDX24)

Snowflake delivered better-than-expected Q3 results and provided upbeat guidance, lifting investor sentiment. Its stock jumped about 20% in after-hours trading.

While Zimmer Biomet has lagged behind the broader market over the past year, analysts continue to hold a moderately positive view on the stock's prospects.

This standout stock from the 'Magnificent 7' group is recommended for purchase with a projected 32% upside potential.

Hilton Worldwide has outpaced the broader market over the past year, with analysts maintaining a moderately optimistic outlook on its future performance.

Hologic has underperformed the broader market over the past year, but Wall Street analysts are moderately optimistic about the stock’s future.

While CarMax has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s future.

U.S. stock markets have performed mixed in November. The first week of this month was a fabulous due to Donald Trump’s massive win as the 47Th president of the United States and the Fed’s decision...

Although Entergy has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

After battling some wind coming out of the ‘sales’ on NVDA’s earnings, and a wave of risk-off due to increasingly heightened tensions between Russia and Ukraine, E-mini S&P futures have traded positive...

While CME Group has underperformed the broader market and its peers over the past year, Wall Street analysts are cautiously optimistic about the stock’s future.